U.S. flag

An official website of the United States government

nsv7093598

  • Variant Calls:1
  • Validation:Not tested
  • Clinical Assertions: Yes
  • Region Size:1

Genome View

Select assembly:
Overlapping variant regions from other studies: 127 SVs from 26 studies. See in: genome view    
Submitted genomic31,338,117-31,338,117Question Mark
Overlapping variant regions from other studies: 127 SVs from 26 studies. See in: genome view    
Submitted genomic29,665,135-29,665,135Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeAssemblyAssembly UnitSequence IDChrStartStop
nsv7093598Submitted genomicGRCh38 (hg38)Primary AssemblyNC_000017.11Chr1731,338,11731,338,117
nsv7093598Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000017.10Chr1729,665,13529,665,135

Variant Call Information

Variant Call IDTypeMethodAnalysisSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv18786016insertionMultipleMultipleNEUROFIBROMATOSIS, TYPE I; NF1; Neurofibromatosis 1; Neurofibromatosis type 1; Neurofibromatosis, type 1; See individual phenotypes in OMIM allelic variantsPathogenicClinVarRCV002875628.1, VCV002022538.1

Variant Call Placement Information

Variant Call IDPlacement TypeHGVSAssemblySequence IDChrStartStop
nssv18786016Submitted genomicNC_000017.11:g.313
38117_31338118ins1
17
GRCh38 (hg38)NC_000017.11Chr1731,338,11731,338,117
nssv18786016Submitted genomicNC_000017.10:g.296
65135_29665136ins1
17
GRCh37 (hg19)NC_000017.10Chr1729,665,13529,665,135

No validation data were submitted for this variant

Clinical Assertions

Variant Call IDHGVSTypeAllele OriginSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv18786016GRCh37: NC_000017.10:g.29665135_29665136ins117, GRCh38: NC_000017.11:g.31338117_31338118ins117insertiongermlineNEUROFIBROMATOSIS, TYPE I; NF1; Neurofibromatosis 1; Neurofibromatosis type 1; Neurofibromatosis, type 1; See individual phenotypes in OMIM allelic variantsPathogenicClinVarRCV002875628.1, VCV002022538.1

No genotype data were submitted for this variant

Support Center